Does photodynamic therapy have the necessary attributes to become a future treatment for organ-confined prostate cancer? - Wikidata - awgldk - TriplyDB

Does photodynamic therapy have the necessary attributes to become a future treatment for organ-confined prostate cancer?

Does photodynamic therapy have the necessary attributes to become a future treatment for organ-confined prostate cancer?

http://www.wikidata.org/entity/Q33223078

about

Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen Vascular targeted photochemotherapy using padoporfin and padeliporfin as a method of the focal treatment of localised prostate cancer - clinician's insight Photodynamic therapy for prostate cancer--an emerging approach for organ-confined disease.Photoactive Ruthenium Nitrosyls: Effects of Light and Potential Application as NO Donors.Photocytotoxicity of the fluorescent nonsteroidal androgen receptor ligand TDPQ.Temoporfin (Foscan®, 5,10,15,20-tetra(m-hydroxyphenyl)chlorin)--a second-generation photosensitizer.Multiparametric magnetic resonance imaging in the management and diagnosis of prostate cancer: current applications and strategies.Realtime light dosimetry software tools for interstitial photodynamic therapy of the human prostate.

P2860

Q24647328-CE9D7C2A-F15A-4518-AF03-D9F9CCD277E9 Q26750559-F99FFCAA-07D4-450C-914B-892B5F93DED5 Q34068220-82152702-BB0E-4181-A65E-711BD2B77773 Q34259551-6CBE2269-248E-4A04-A1A5-E868D2288F08 Q36921374-050E04C6-EB91-48DA-B25F-F816C2CEBDFA Q37919156-2410AA9A-AEF4-42F8-B94E-505ECE615D96 Q38178850-851BB2B0-EE05-4884-92AA-62491F309EC9 Q51898660-29853849-5321-43C5-B061-0C4CF65879D9

P2860

Does photodynamic therapy have the necessary attributes to become a future treatment for organ-confined prostate cancer?

http://www.wikidata.org/entity/Q33223078

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Does photodynamic therapy have ...... rgan-confined prostate cancer?

@ast

Does photodynamic therapy have ...... rgan-confined prostate cancer?

@en

type

label

Does photodynamic therapy have ...... rgan-confined prostate cancer?

@ast

Does photodynamic therapy have ...... rgan-confined prostate cancer?

@en

prefLabel

Does photodynamic therapy have ...... rgan-confined prostate cancer?

@ast

Does photodynamic therapy have ...... rgan-confined prostate cancer?

@en

P1433

Q33223078-7197C1DA-FC90-42E7-9FE8-66507E33FA9B

P1476

Q33223078-DD8D0592-B887-46AB-8413-E661BC01DE02

P2093

Q33223078-1D1DDB6A-5AB9-461A-A222-3FC7FE3BF7C9

Q33223078-7DB17ED5-865E-49B8-AF4E-0798068A68DD

P2860

Q33223078-01AE764C-5DAE-4C05-843A-2A6F0F0C9229

Q33223078-08324E19-18F0-4ACA-9068-DDA9A0B83EA3

Q33223078-0AC502EF-4A12-4383-AD0E-CA79AE2B8A0F

Q33223078-1B0475E4-591D-4C9D-A511-DF1C7C21449B

Q33223078-1D0A7B43-B55A-4E56-88C0-8448AC7BDC3F

Q33223078-564D593D-4786-4673-9866-893C61D82388

Q33223078-5F697086-4B49-4D1E-B129-F587A4F7EA0E

Q33223078-60B91E43-ECC1-453C-81BA-44BE9E4C3309

Q33223078-617396D8-3373-4774-A662-890A3D06CF26

Q33223078-6B7D2087-A90D-40F3-9294-1F7E68B00F8E

P304

Q33223078-F042EB0D-7D4B-42F7-A77A-E7760416629A

P31

Q33223078-6BE8CDF0-DD3D-41C9-88E7-045733917AB4

P356

Q33223078-78DC509C-EA97-4EF7-B0D4-03C419D52DC7

P433

Q33223078-55C13705-A230-4A28-BBCB-DBDC753BF1C0

P478

Q33223078-68EDA009-1D97-469D-89A4-757FA4271305

P50

Q33223078-3D9FB415-3408-42A8-8D43-9AEAE68B90A8

Q33223078-6BFDED11-69BA-47A7-B130-5BA00CE19399

P577

Q33223078-31BE4971-FDD2-43F4-8F3B-C5127A0C9FAD

P698

Q33223078-033BD042-E1EF-4B67-9698-1292A1C8C398

P356

J.1464-410X.2005.05709.X

P1433

BJU International

P1476

Does photodynamic therapy have ...... rgan-confined prostate cancer?

@en

P2093

Ivan M Hoh

http://www.w3.org/2001/XMLSchema#string

Stephen G Bown

http://www.w3.org/2001/XMLSchema#string

P2860

Antivascular treatment of solid melanoma tumors with bacteriochlorophyll-serine-based photodynamic therapy.

The patient's dilemma: prostate cancer treatment choices.

Clinical outcomes of photodynamic therapy for head-and-neck cancer.

Interstitial photodynamic therapy as salvage treatment for recurrent head and neck cancer

Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study.

Photodynamic therapy with Pd-Bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenografts.

The immunological consequences of photodynamic treatment of cancer, a literature review.

Targeted photodynamic therapy via receptor mediated delivery systems.

High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.

'Vanishing' prostate cancer in radical prostatectomy specimens: incidence and long-term follow-up in 38 cases.

P304

754-758

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1464-410X.2005.05709.X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16153193

http://www.w3.org/2001/XMLSchema#string